Addressing Obesity: A Community of Practice: Pharmacologic Options for the Treatment of Obesity Webinar
Addressing Obesity: A Community of Practice is designed to create a community for PAs to participate in CME and other learning activities, collaborate, and share best practices, research, and evidence-based knowledge on obesity management and treatment. This will serve as a community where all PAs, regardless of practice setting or specialty, can come together to share and discuss current and relevant research and evidence-based approaches to obesity care. Join the Huddle Subcommunity, subscribe to daily digest emails, participate in Ask Me Sessions, and earn CME with interactive real-world experiences patient scenarios, live webinars, and webinar replays.
As part of the series of activities on Addressing Obesity: A Community of Practice, this recorded webinar will focus on principles of pharmacological treatment of obesity across a range of patients based on characteristics. You will learn to formulate long-term obesity treatment plans based on patient characteristics, comorbid conditions and complications, preferences, and access.
This activity is supported by an educational grant from Lilly.
As part of the series of activities on Addressing Obesity: A Community of Practice, this recorded webinar will focus on principles of pharmacological treatment of obesity across a range of patients based on characteristics. You will learn to formulate long-term obesity treatment plans based on patient characteristics, comorbid conditions and complications, preferences, and access.
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Select anti-obesity medications for appropriate patients based on patient characteristics
- Formulate a long-term treatment plan for obesity based on patient characteristics, comorbid conditions and complications, preferences, and access
RELATED ACTIVITIES
Addressing Obesity: A Community of Practice Series
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Lilly.